Cardiology & Atherosclerosis Prophylaxis
Rozusprin 10/75
Rosuvastatin Calcium 10mg + Aspirin 75mg
Synergistic cardiovascular capsule combining an HMG-CoA reductase inhibitor for aggressive LDL reduction with low-dose enteric-coated aspirin for antiplatelet aggregation.
Standardized Actives
Rosuvastatin Calcium IP eq. to Rosuvastatin 10mg + Aspirin IP 75mg (Enteric Coated).
Therapeutic Purpose
- Secondary prevention of cardiovascular events in dyslipidemic patients
- Primary hypercholesterolemia with high atherosclerotic cardiovascular risk
- Coronary artery disease and post-percutaneous coronary intervention (PCI)
- Reduction of thrombotic risk in arterial occlusive disorders
Administration & Care
1 capsule once daily with water, preferably at bedtime or as directed by Cardiologist.
Strip of 10 capsules in protective Alu-Alu foil. — Store below 30°C in a dry place. Protect from moisture.
Quality, Safety & Manufacturing Standards
Every batch of Aanav Healthcare formulations is manufactured under strict current Good Manufacturing Practices (cGMP) in licensed facilities in Mumbai, India. We subject all active pharmaceutical ingredients and botanical extracts to multi-stage purity, stability, and assay tests.
- Product Title
- Rozusprin 10/75 (Rosuvastatin Calcium 10mg + Aspirin 75mg)
- Therapeutic Segment
- Cardiology & Atherosclerosis Prophylaxis — Cardiology
- Active Formula
- Rosuvastatin Calcium IP eq. to Rosuvastatin 10mg + Aspirin IP 75mg (Enteric Coated).
- Dosage & Use
- 1 capsule once daily with water, preferably at bedtime or as directed by Cardiologist.
- Pack Packaging
- Strip of 10 capsules in protective Alu-Alu foil.
- Storage Guidelines
- Store below 30°C in a dry place. Protect from moisture.
- Regulatory Compliance
- Schedule H Prescription Drug — cGMP Certified.
